Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The beta-1 adrenergic receptor (ADRB1) is a G-protein-coupled receptor that mediates physiological responses to catecholamines, particularly epinephrine and norepinephrine. It is predominantly expressed in cardiac tissue and regulates heart rate, contractility, and conduction velocity. Activation increases cardiac output. It is a major drug target for cardiovascular diseases, especially hypertension, arrhythmias, and heart failure.
Beta-1 adrenergic receptor antagonists (beta-blockers) inhibit the activity of the receptor, reducing heart rate and contractility.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenergic Receptor Beta 1 (ADRB1).